invest1 publisher
Kenya's LLM trial hangs on roughly 196 treatment failures among 9,347 patients
In the Penda Health trial, LLM support improved documentation and treatment plans while 14-day failure ran 2.2% against 2%, and the FDA's discussion paper on how to evaluate such tools is still only collecting comments.
Publishers:cryptopolitan.com
Reality
- Evidence45
- Adoption45
- Hype gap−10
- Incentives55
- Confidence50